Le Lézard
Classified in: Health
Subjects: LEG, AVO

PatientRightsAdvocate.org Applauds Gov. Polis Signing Bipartisan Hospital Price Transparency Bill into Law


New law "a triumph for Colorado patients over secrecy and special interests"

WASHINGTON, June 2, 2023 /PRNewswire/ -- PatientRightsAdvocate.org (PRA) celebrated today's signing of Senate Bill 252 by Colorado Governor Jared Polis at a public ceremony in Denver. The bipartisan legislation requires Colorado hospitals to comply with federal price transparency rules by posting all of their prices upfront and in full for the public to see. According to PRA's most recent Hospital Price Transparency Compliance Report, 100 percent of hospitals reviewed in Colorado are failing to fully comply with the rules and denying patients their right to know the complete and accurate price of their services.

"Today is a bright day for all Coloradoans," said PRA Founder and Chairman Cynthia Fisher. "No longer will hospitals be able to hide prices and keep patients in the dark. No more overcharges, no more surprise billing, no more exploitation. Real transparency will usher in a fair and competitive marketplace in which all healthcare consumers are empowered with more choices that will reduce costs and improve care."

More than two years since the federal price transparency rule took effect in 2021, fewer than 25 percent of America's hospitals have fully complied with its requirements. Meanwhile, throughout the nation approximately 100 million Americans are burdened by medical debt often caused by sky-high hospital expenses to which they could not consent.

The lack of healthcare price transparency has directly harmed patients like Cyndy Reddy, a resident of Broomfield, Colorado. In a video for PRA's Patient Voices public awareness campaign, Cyndy shared her story of being saddled with crippling debt following overcharges for a hysterectomy for which she was not given an upfront price. Cyndy's story can be watched here.

"This indispensable new law is a triumph for Colorado patients over secrecy and special interests and serves as a model for other state governments to follow," Fisher added. "Families suffering from runaway healthcare costs now have new hope. I thank Governor Polis and each of the legislators from both parties for working together to bring this solution to life in order to protect patients and lower costs."

SB 252 was introduced earlier this year by Colorado Senators Kevin Van Winkle (R) and Julie Gonzales (D) and Representatives Lindsey Daugherty (D) and Anthony Hartsook (R). It was passed by the state Senate on April 19, 2023, by a bipartisan vote of 22-11; it was then passed by the state House on May 7, 2023, by a bipartisan vote of 61-3.

The new law strengthens enforcement of price transparency requirements and makes noncompliance a violation of the state's Deceptive Trade Practices Act. It also allows the State's Department of Health Care and Policy and Financing to monitor compliance with the requirements, publish the results on its website, and recommend civil monetary penalties to be issued by the attorney general.

About PRA

PatientRightsAdvocate.org (PRA) is a leading national healthcare price transparency organization dedicated to ushering in systemwide transparency through advocacy, testimony, media, legal research, and grassroots campaigns. PRA believes that the availability and visibility of actual, upfront healthcare prices will greatly lower costs for patients and employers through a functional, competitive healthcare marketplace.

Click here to view PRA's "Patient Voices" ad campaign.

SOURCE Patient Rights Advocate


These press releases may also interest you

at 07:25
Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today...

at 07:20
Baxter International Inc. , a global medtech leader, today reported results for the first quarter of 2024. "Baxter's results in the first quarter reflect the company's solid operational performance, fueled by the benefits being realized from our...

at 07:10
Bruker Corporation is pleased to announce the closing of its acquisition of ELITechGroup ("ELITech") for ?870 million in cash, excluding the carved out ELITech clinical chemistry business. ELITech is a differentiated, fast growing and profitable...

at 07:10
Novocure today reported financial results for the quarter ended March 31, 2024. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer by developing and commercializing its innovative therapy,...

at 07:10
Novocure announced today that it has entered into a new five-year up to $400 million committed senior secured credit facility with funds managed by Pharmakon Advisors, LP. The committed capital will be available to Novocure in four tranches of $100...

at 07:10
Bicycle Therapeutics plc , a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported recent business progress and financial results for the...



News published on and distributed by: